The role of therapeutic drug monitoring in treatment of HIV infection

被引：44

作者：

Back, DJ

Khoo, SH

Gibbons, SE

Merry, C

机构：

[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England

[2] Northwestern Univ, Sch Med, Comprehens AIDS Ctr, Chicago, IL 60611 USA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2001年 / 51卷 / 04期

关键词：

inhibitory quotient; pharmacoenhancement; protease inhibitors; therapeutic drug monitoring;

D O I：

10.1046/j.1365-2125.2001.01380.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：301 / 308

页数：8

共 44 条

[1]

ACOSTA EP, 1997, 37 INT C ANT AG CHEM

[2]

*AIDS CLIN TRIALS, 1999, 9 ANN CLIN CAR OPT H

[3]

*ASS, BRIT HIV

[4]

BACK D, 2000, 7 C RETR OPP INF SAN

[5] Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection [J].

Barry, M ;

Mulcahy, F ;

Merry, C ;

Gibbons, S ;

Back, D .

CLINICAL PHARMACOKINETICS, 1999, 36 (04) :289-304

[6]

Barry MG, 1998, BRIT J CLIN PHARMACO, V45, P501

[7] The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites [J].

Barry, MG ;

Khoo, SH ;

Veal, GJ ;

Hoggard, PG ;

Gibbons, SE ;

Wilkins, EGL ;

Williams, O ;

Breckenridge, AM ;

Back, DJ .

AIDS, 1996, 10 (12) :1361-1367

[8]

Burger DM, 1998, ANTIVIR THER, V3, P215

[9]

Burger DM, 1998, AIDS, V12, pS61

[10]

BURGER DM, 1998, 12 WORLD AIDS C GEN

← 1 2 3 4 5 →